Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02080
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

NRL Knockdown by AAV-delivered CRISPR/Cas9 Prevents Retinal Degeneration in Mice

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

The Comparison Between HBV Transgenic Mice and Normal Mice After Being Injected Concanavalin a (Con A)

Pharmaceutical Analytical Chemistry
2017English

The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in Vivo and Regulated via Doxycycline and Cre-Recombinase

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2018English

Occult HBV Infection

ACTUAL INFECTOLOGY
2018English

Regulation of Transforming Growth Factor-Beta 1 Expression by the Hepatitis B Virus (HBV) X Transactivator. Role in HBV Pathogenesis.

Journal of Clinical Investigation
Medicine
1996English

HBV Core Protein

Science-Business eXchange
2013English

HBV Infection Suppresses the Expression of Inflammatory Macrophage miR‑210

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Effects of Antiviral Therapy on Post-Hepatectomy HBV Reactivation and Liver Function in HBV DNA-negative Patients With HBV-related Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Activation of Hepatic Stem Cells Compartment During Hepatocarcinogenesis in a HBsAg HBV-transgenic Mouse Model

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy